A detailed history of Maven Securities LTD transactions in Catalent, Inc. stock. As of the latest transaction made, Maven Securities LTD holds 84,000 shares of CTLT stock, worth $4.72 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
84,000
Holding current value
$4.72 Million
% of portfolio
0.29%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$42.56 - $59.82 $3.58 Million - $5.02 Million
84,000 New
84,000 $4.74 Million
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $3.25 Million - $4.01 Million
-32,000 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$85.88 - $105.36 $2.75 Million - $3.37 Million
32,000 New
32,000 $3.33 Million
Q4 2017

Feb 08, 2018

SELL
$37.27 - $43.02 $745,400 - $860,400
-20,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $675,000 - $833,400
20,000
20,000 $792,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.1B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.